Ultrasound Precision Care Education Room

As breast density awareness and supplemental screening requirements continue to grow, healthcare providers face increasing pressure to deliver high-quality, scalable screening services. In this session, Dr. Georgia Spear will discuss her experience implementing a large-scale dense breast screening program powered by Invenia™ ABUS and advanced AI technologies, such as QVCAD™. Attendees will gain practical insights into program design, workflow optimization, clinical outcomes, and strategies for the sustainable growth of an ABUS program. The discussion will also highlight the role of ABUS within a complementary, multi-modality breast imaging approach, supporting personalized screening pathways for women with dense breast tissue. In addition, the session will explore how ABUS can support the early detection of breast cancer through a non-invasive, radiation-free, and well-tolerated imaging experience, designed to improve patient outcomes while expanding access to supplemental screening.

QVCAD is a trademark of QView Medical, Inc.